Request for Covid-19 Impact Assessment of this Report
Market Dynamics
Since healthcare prescriptive analytics is the next step of predictive analytics, many drivers and inhibitors are similar for both markets. The primary market driver is the need to implement efficient process regarding cost cutting and reduction of unnecessary efforts. This will ensure utilization of resources in a proper manner. Furthermore, because of integration of Big Data in healthcare, the requirement of prescriptive analysis to create action plans based on past trends will expand. Additionally, with increasing advancements in technology, need to develop prescriptive analytics will form the competitive edge and thus, because of movement towards prescriptive analytics, growth will be further enhanced. However, due to high costs associated with the initial investment required to establish prescriptive analytics system, the increase will get negatively affected. The issue of initial investment is further escalated by the costs associated with training labor to understand the nuances of technology and therefore, lack of availability of skilled IT labors acts as another inhibitor of the market growth. Apart from these factors, growing concerns about data privacy and security of the same impacts the procurement of necessary data required to generate data based solutions.
Market Segmentation
The major forms of segmentation of healthcare predictive analytics market include segmentation by component, by application, by deployment, by end-user and by geography. By component, software, hardware and services cover the entire market. By application, a market is categorized as Clinical Analysis, Financial Analysis, Operational Analysis and Research Analysis. Segmentation through deployment includes On-Premise, Web-based and Cloud-based. By end-user, segmentation comprises Physicians, Private Organizations, Hospitals, Clinics and, Government and Research Institutions. By geography, North America, Europe, Asia-Pacific and, Middle East and Africa form the entire market. Currently, Clinical Analytics segment is forecasted to have the maximum growth in application segmentation. Although Cloud-based services are gaining traction massively, yet, On-Premise solutions have captured the highest market share in deployment category.
Geographical Analysis
North America is leading the market because of the presence of giants like IBM and Oracle. Europe is following North America with second most significant market share. Asia-Pacific region is expected to grow at highest growth rate.
Key Players
The critical players in the market include IBM, Cerner, Oracle, MedeAnalytics Inc., McKesson Corporation, Optum Inc. and AllScripts Healthcare Solutions Inc.
Report Contents:
> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players
Regional Analysis:
> North America
>> US and Canada
> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
Report Highlights:
> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...